A detailed history of Callan Capital, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Callan Capital, LLC holds 3,172 shares of MDT stock, worth $271,999. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,172
Previous 2,626 20.79%
Holding current value
$271,999
Previous $206,000 38.35%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.84 - $91.03 $41,954 - $49,702
546 Added 20.79%
3,172 $285,000
Q2 2024

Aug 12, 2024

BUY
$78.71 - $87.02 $21,802 - $24,104
277 Added 11.79%
2,626 $206,000
Q1 2024

Oct 22, 2024

SELL
$82.84 - $88.09 $22,946 - $24,400
-277 Reduced 10.55%
2,349 $204,000
Q1 2024

May 03, 2024

BUY
$82.84 - $88.09 $194,591 - $206,923
2,349 New
2,349 $204,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.